Equitable Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Sell |
4,300
-526
| -11% | -$213K | 0.01% | 614 |
|
|
2025
Q1 | $2.4M | Buy |
4,826
+555
| +13% | +$276K | 0.02% | 460 |
|
|
2024
Q4 | $2.22M | Buy |
4,271
+601
| +16% | +$313K | 0.02% | 463 |
|
|
2024
Q3 | $2.27M | Buy |
3,670
+890
| +32% | +$551K | 0.02% | 457 |
|
|
2024
Q2 | $1.54M | Buy |
2,780
+428
| +18% | +$237K | 0.02% | 537 |
|
|
2024
Q1 | $1.37M | Sell |
2,352
-37
| -2% | -$21.5K | 0.02% | 545 |
|
|
2023
Q4 | $1.27M | Buy |
2,389
+239
| +11% | +$127K | 0.02% | 525 |
|
|
2023
Q3 | $1.09M | Buy |
2,150
+131
| +6% | +$66.3K | 0.02% | 519 |
|
|
2023
Q2 | $1.05M | Buy |
2,019
+115
| +6% | +$60K | 0.02% | 505 |
|
|
2023
Q1 | $1.1M | Sell |
1,904
-35
| -2% | -$20.2K | 0.02% | 448 |
|
|
2022
Q4 | $1.07M | Buy |
1,939
+153
| +9% | +$84.3K | 0.02% | 429 |
|
|
2022
Q3 | $906K | Buy |
1,786
+154
| +9% | +$78.1K | 0.02% | 415 |
|
|
2022
Q2 | $887K | Buy |
1,632
+121
| +8% | +$65.8K | 0.02% | 433 |
|
|
2022
Q1 | $892K | Buy |
1,511
+82
| +6% | +$48.4K | 0.01% | 435 |
|
|
2021
Q4 | $953K | Buy |
1,429
+4
| +0.3% | +$2.67K | 0.02% | 410 |
|
|
2021
Q3 | $814K | Sell |
1,425
-105
| -7% | -$60K | 0.01% | 428 |
|
|
2021
Q2 | $772K | Buy |
1,530
+30
| +2% | +$15.1K | 0.01% | 432 |
|
|
2021
Q1 | $685K | Sell |
1,500
-17
| -1% | -$7.76K | 0.01% | 437 |
|
|
2020
Q4 | $707K | Buy |
1,517
+33
| +2% | +$15.4K | 0.02% | 384 |
|
|
2020
Q3 | $655K | Buy |
1,484
+200
| +16% | +$88.3K | 0.02% | 371 |
|
|
2020
Q2 | $465K | Buy |
1,284
+135
| +12% | +$48.9K | 0.01% | 425 |
|
|
2020
Q1 | $326K | Sell |
1,149
-152
| -12% | -$43.1K | 0.01% | 445 |
|
|
2019
Q4 | $423K | Buy |
+1,301
| New | +$423K | 0.01% | 433 |
|